Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Gliosarcoma - Overview
Gliosarcoma - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Gliosarcoma - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Gliosarcoma - Companies Involved in Therapeutics Development
A. Merini Industrie Farmaceutiche Riunite Srl
Aettis Inc
Apexigen Inc
Arog Pharmaceuticals Inc
Bayer AG
Berg LLC
Biohaven Pharmaceutical Holding Company Ltd
Bristol-Myers Squibb Co
Calithera Biosciences Inc
CDG Therapeutics Inc
Chimerix Inc
Cothera Bioscience Pty Ltd
Dtrix Inc
EpicentRx Inc
ERC Belgium SA
F. Hoffmann-La Roche Ltd
Fore Biotherapeutics Inc
Genexine Inc
Ipsen SA
Kazia Therapeutics Ltd
Kintara Therapeutics Inc
Lentigen Technology Inc
Merck & Co Inc
Merck KGaA
Mustang Bio Inc
Novartis AG
OncXer Therapeutics Inc
Samus Therapeutics Inc
TheraBiologics Inc
Transtarget Inc
Vascular Biogenics Ltd
Vigeo Therapeutics Inc
Gliosarcoma - Drug Profiles
atezolizumab - Drug Profile
Product Description
Mechanism Of Action
avadomide hydrochloride - Drug Profile
Product Description
Mechanism Of Action
bavituximab - Drug Profile
Product Description
Mechanism Of Action
CB-NK-TGF-betaR2 - Drug Profile
Product Description
Mechanism Of Action
Cellular Immunotherapy for Oncology - Drug Profile
Product Description
Mechanism Of Action
Cellular Immunotherapy for Oncology - Drug Profile
Product Description
Mechanism Of Action
Cellular Immunotherapy to Target CD3 and EGFR for Oncology - Drug Profile
Product Description
Mechanism Of Action
crenolanib besylate - Drug Profile
Product Description
Mechanism Of Action
dianhydrogalactitol - Drug Profile
Product Description
Mechanism Of Action
efineptakin alfa - Drug Profile
Product Description
Mechanism Of Action
ERC-1671 - Drug Profile
Product Description
Mechanism Of Action
FORE-8394 - Drug Profile
Product Description
Mechanism Of Action
G-207 - Drug Profile
Product Description
Mechanism Of Action
icapamespib - Drug Profile
Product Description
Mechanism Of Action
ipilimumab - Drug Profile
Product Description
Mechanism Of Action
ipilimumab + nivolumab - Drug Profile
Product Description
Mechanism Of Action
irinotecan hydrochloride - Drug Profile
Product Description
Mechanism Of Action
LG-631 - Drug Profile
Product Description
Mechanism Of Action
lofarnib - Drug Profile
Product Description
Mechanism Of Action
M-032 - Drug Profile
Product Description
Mechanism Of Action
marizomib - Drug Profile
Product Description
Mechanism Of Action
MB-108 - Drug Profile
Product Description
Mechanism Of Action
NU-0129 - Drug Profile
Product Description
Mechanism Of Action
ofranergene obadenovec - Drug Profile
Product Description
Mechanism Of Action
ONC-201 - Drug Profile
Product Description
Mechanism Of Action
ONC-206 - Drug Profile
Product Description
Mechanism Of Action
P-28 - Drug Profile
Product Description
Mechanism Of Action
paxalisib - Drug Profile
Product Description
Mechanism Of Action
pazopanib hydrochloride - Drug Profile
Product Description
Mechanism Of Action
pembrolizumab - Drug Profile
Product Description
Mechanism Of Action
relatlimab - Drug Profile
Product Description
Mechanism Of Action
RRX-001 - Drug Profile
Product Description
Mechanism Of Action
sabatolimab - Drug Profile
Product Description
Mechanism Of Action
sapanisertib - Drug Profile
Product Description
Mechanism Of Action
SL-701 - Drug Profile
Product Description
Mechanism Of Action
sorafenib tosylate - Drug Profile
Product Description
Mechanism Of Action
sotigalimab - Drug Profile
Product Description
Mechanism Of Action
tasadenoturev - Drug Profile
Product Description
Mechanism Of Action
TBX.OncV NSC - Drug Profile
Product Description
Mechanism Of Action
tepotinib hydrochloride - Drug Profile
Product Description
Mechanism Of Action
troriluzole hydrochloride - Drug Profile
Product Description
Mechanism Of Action
ubidecarenone - Drug Profile
Product Description
Mechanism Of Action
urelumab - Drug Profile
Product Description
Mechanism Of Action
vorinostat - Drug Profile
Product Description
Mechanism Of Action
VT-1021 - Drug Profile
Product Description
Mechanism Of Action
zotiraciclib citrate - Drug Profile
Product Description
Mechanism Of Action
Gliosarcoma - Dormant Projects
Gliosarcoma - Discontinued Products
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Gliosarcoma, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Top 10 Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Top 10 Routes of Administration, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Top 10 Molecule Types, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022

List of Tables

List of Tables
Number of Products under Development for Gliosarcoma, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Gliosarcoma - Dormant Projects, 2022
Gliosarcoma - Discontinued Products, 2022